Founded in September 2020 by Philippe Van Wesepoel and Jean François Plucker, OLYS Pharma is an innovative biotech aiming to improve the quality of life of patients suffering from neurogenic inflammation whose painful symptoms are found in many chronic pathologies.
Concretely, the Start-Up’s research focuses on the treatment and prevention of neurogenic inflammation of the Neuro-Immuno-Cutaneous-Endocrine (NICE) system.
Beyond Thinking for Better Health
Taking a fresh look, going beyond the obvious and with our continual questioning, we are driven by an unwavering desire to learn and understand.
This is how OLYS Pharma develops innovative and ever more effective treatments to restore the quality of life of suffering patients.
OLYS Pharma defends strong and firmly anchored values.
“Guided by passion and curiosity, our pursuit is excellence. We build bridges and ethics are found in everything we do. We innovate, walk outside the box and create entirely new technology”.
BOARD OF DIRECTORS